The White House recently imposed sweeping new tariffs on a wide variety of imported goods.
The good news for patients is that pharmaceutical products are not subject to these so-called "reciprocal tariffs" -- for now. But that soon may change, as President Donald Trump has suggested that we'll still see pharma-specific tariffs "at some point."
